• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

新型平面手性联[2.2]对环芳烷的合成--([2.2]-对环芳基碳酰胺基)-4-([2.2]对环芳基甲酰胺基)、[2.2]对环芳基取代三唑硫酮和-取代恶二唑。

Synthesis of New Planar-Chiral Linked [2.2]Paracyclophanes--([2.2]-Paracyclophanylcarbamoyl)-4-([2.2]Paracyclophanylcarboxamide, [2.2]Paracyclophanyl-Substituted Triazolthiones and -Substituted Oxadiazoles.

机构信息

Chemistry Department, Faculty of Science, Minia University, El-Minia 61519, Egypt.

Institute of Organic Chemistry, Karlsruhe Institute of Technology, 76131 Karlsruhe, Germany.

出版信息

Molecules. 2020 Jul 22;25(15):3315. doi: 10.3390/molecules25153315.

DOI:10.3390/molecules25153315
PMID:32707754
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7436044/
Abstract

The manuscript describes the synthesis of new racemic and chiral linked paracyclophane assigned as -5-(1,4(1,4)-dibenzenacyclohexaphane-1-yl)carbamoyl)-5'-(1,4(1,4)-dibenzenacyclohexaphane-1-yl)carboxamide. The procedure depends upon the reaction of 5-(1,4(1,4)-dibenzenacyclohexaphane-1-yl)hydrazide with 5-(1,4(1,4)-dibenzenacyclohexaphane-1-yl)isocyanate. To prepare the homochiral linked paracyclophane of a compound, the enantioselectivity of 5-(1,4(1,4)-dibenzenacyclohexaphane-1-yl)carbaldehyde (enantiomeric purity 60% ee), was oxidized to the corresponding acid, which on chlorination, gave the corresponding acid chloride of [2.2]paracyclophane. Following up on the same procedure applied for the preparation of racemic-carbamoyl and purified by HPLC purification, we succeeded to obtain the target ---5-(1,4(1,4)-dibenzenacyclohexaphane-1-yl)carbamoyl)-5'-(1,4(1,4)-dibenzenacyclohexaphane-1-yl)carboxamide. Subjecting -5-(1,4(1,4)-dibenzenacyclohexaphane-1-yl)hydrazide to various isothiocyanates, the corresponding paracyclophanyl-acylthiosemicarbazides were obtained. The latter compounds were then cyclized to a new series of 5-(1,4(1,4)-dibenzenacyclohexaphane-1-yl)-2,4-dihydro-3-1,2,4-triazol-3-thiones. 5-(1,4(1,4)-Dibenzenacyclohexaphane-1-yl)-1,3,4-oxadiazol-2-amines were also synthesized in good yields via internal cyclization of the same paracyclophanyl-acylthiosemicarbazides. NMR, IR, and mass spectra (HRMS) were used to elucidate the structure of the obtained products. The X-ray structure analysis was also used as an unambiguous tool to elucidate the structure of the products.

摘要

该手稿描述了新的外消旋和手性连接的对环芳烷的合成,其被指定为 -5-(1,4(1,4)-二苯并环己烷-1-基)氨甲酰基)-5'-(1,4(1,4)-二苯并环己烷-1-基)羧酰胺。该过程取决于 5-(1,4(1,4)-二苯并环己烷-1-基)酰肼与 5-(1,4(1,4)-二苯并环己烷-1-基)异氰酸酯的反应。为了制备化合物的同手性连接的对环芳烷,对 5-(1,4(1,4)-二苯并环己烷-1-基)甲醛(对映体纯度 60%ee)的手性选择性进行了氧化,得到相应的酸,该酸经氯化后得到 [2.2]对环芳烷的相应酰氯。按照同样的制备外消旋-氨甲酰基的程序进行,并通过 HPLC 纯化进行纯化,我们成功地获得了目标化合物 ---5-(1,4(1,4)-二苯并环己烷-1-基)氨甲酰基)-5'-(1,4(1,4)-二苯并环己烷-1-基)羧酰胺。将 -5-(1,4(1,4)-二苯并环己烷-1-基)酰肼与各种异硫氰酸酯反应,得到相应的对环芳烷酰基硫代半卡巴肼。然后,将后者化合物环化,得到一系列新的 5-(1,4(1,4)-二苯并环己烷-1-基)-2,4-二氢-3-1,2,4-三唑-3-硫酮。通过相同的对环芳烷酰基硫代半卡巴肼的内部环化,也以良好的产率合成了 5-(1,4(1,4)-二苯并环己烷-1-基)-1,3,4-恶二唑-2-胺。使用 NMR、IR 和质谱(高分辨率质谱)(HRMS)阐明了所得产物的结构。还使用 X 射线结构分析作为阐明产物结构的明确工具。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cc5a/7436044/02aaa76924f9/molecules-25-03315-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cc5a/7436044/9bd8309f2152/molecules-25-03315-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cc5a/7436044/a8a0375431c9/molecules-25-03315-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cc5a/7436044/07ba5a839d12/molecules-25-03315-sch001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cc5a/7436044/e251cef0f6e4/molecules-25-03315-sch002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cc5a/7436044/cdd82e4e6c7d/molecules-25-03315-sch003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cc5a/7436044/cd2d9c0f4a6a/molecules-25-03315-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cc5a/7436044/dfbbb37734ec/molecules-25-03315-sch004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cc5a/7436044/25d84fb33d8e/molecules-25-03315-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cc5a/7436044/521a4bc2b896/molecules-25-03315-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cc5a/7436044/72a8d8c9bf62/molecules-25-03315-sch005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cc5a/7436044/1ee02b8e8be2/molecules-25-03315-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cc5a/7436044/ffb8d5ba03fd/molecules-25-03315-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cc5a/7436044/23f76f476fd7/molecules-25-03315-sch006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cc5a/7436044/c5a738759ce2/molecules-25-03315-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cc5a/7436044/02aaa76924f9/molecules-25-03315-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cc5a/7436044/9bd8309f2152/molecules-25-03315-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cc5a/7436044/a8a0375431c9/molecules-25-03315-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cc5a/7436044/07ba5a839d12/molecules-25-03315-sch001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cc5a/7436044/e251cef0f6e4/molecules-25-03315-sch002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cc5a/7436044/cdd82e4e6c7d/molecules-25-03315-sch003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cc5a/7436044/cd2d9c0f4a6a/molecules-25-03315-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cc5a/7436044/dfbbb37734ec/molecules-25-03315-sch004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cc5a/7436044/25d84fb33d8e/molecules-25-03315-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cc5a/7436044/521a4bc2b896/molecules-25-03315-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cc5a/7436044/72a8d8c9bf62/molecules-25-03315-sch005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cc5a/7436044/1ee02b8e8be2/molecules-25-03315-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cc5a/7436044/ffb8d5ba03fd/molecules-25-03315-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cc5a/7436044/23f76f476fd7/molecules-25-03315-sch006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cc5a/7436044/c5a738759ce2/molecules-25-03315-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cc5a/7436044/02aaa76924f9/molecules-25-03315-g009.jpg

相似文献

1
Synthesis of New Planar-Chiral Linked [2.2]Paracyclophanes--([2.2]-Paracyclophanylcarbamoyl)-4-([2.2]Paracyclophanylcarboxamide, [2.2]Paracyclophanyl-Substituted Triazolthiones and -Substituted Oxadiazoles.新型平面手性联[2.2]对环芳烷的合成--([2.2]-对环芳基碳酰胺基)-4-([2.2]对环芳基甲酰胺基)、[2.2]对环芳基取代三唑硫酮和-取代恶二唑。
Molecules. 2020 Jul 22;25(15):3315. doi: 10.3390/molecules25153315.
2
Synthesis of substituted 5-(1,2,4-oxadiazol-5-yl)-3,4-dihydropyrimidine-2(1H)-thiones.取代的5-(1,2,4-恶二唑-5-基)-3,4-二氢嘧啶-2(1H)-硫酮的合成
J Comb Chem. 2009 Mar 9;11(2):216-9. doi: 10.1021/cc800111h.
3
Synthesis and anticancer evaluation of 1,3,4-oxadiazoles, 1,3,4-thiadiazoles, 1,2,4-triazoles and Mannich bases.1,3,4-恶二唑、1,3,4-噻二唑、1,2,4-三唑及曼尼希碱的合成与抗癌活性评价
Chem Pharm Bull (Tokyo). 2015;63(5):369-76. doi: 10.1248/cpb.c15-00059.
4
5-Furan-2yl[1,3,4]oxadiazole-2-thiol, 5-furan-2yl-4H [1,2,4] triazole-3-thiol and their thiol-thione tautomerism.5-呋喃-2-基[1,3,4]恶二唑-2-硫醇、5-呋喃-2-基-4H-[1,2,4]三唑-3-硫醇及其硫醇-硫酮互变异构现象
Molecules. 2005 Feb 28;10(2):475-80. doi: 10.3390/10020475.
5
Synthesis and cytotoxicity of bis-1,3,4-oxadiazoles and bis-pyrazoles derived from 1,4-bis[5-thio-4-substituted-1,2,4-triazol-3-yl]-butane and their DNA binding studies.1,4-双[5-硫代-4-取代-1,2,4-三唑-3-基]-丁烷衍生的双-1,3,4-噁二唑和双吡唑的合成及细胞毒性及其与 DNA 的结合研究。
Arch Pharm (Weinheim). 2011 Apr;344(4):248-54. doi: 10.1002/ardp.201000177. Epub 2011 Jan 17.
6
Synthesis of some novel heterocylic compounds derived from 2-[3-(4-chlorophenyl)-5-(4-methoxybenzyl)-4H-1,2,4-triazol-4-yl]acetohydrazide and investigation of their lipase and α-glucosidase inhibition.由2-[3-(4-氯苯基)-5-(4-甲氧基苄基)-4H-1,2,4-三唑-4-基]乙酰肼衍生的一些新型杂环化合物的合成及其脂肪酶和α-葡萄糖苷酶抑制作用的研究
J Enzyme Inhib Med Chem. 2015 Dec;30(6):1002-9. doi: 10.3109/14756366.2014.1003213. Epub 2015 Feb 2.
7
Synthesis and structure determination of some oxadiazole-2-thione and triazole-3-thione galactosides.一些恶二唑-2-硫酮和三唑-3-硫酮半乳糖苷的合成与结构测定
Nucleosides Nucleotides Nucleic Acids. 2001 Sep;20(9):1671-82. doi: 10.1081/NCN-100105903.
8
Synthesis and antibacterial studies of a new series of 1,2-bis(1,3, 4-oxadiazol-2-yl)ethanes and 1,2-bis(4-amino-1,2, 4-triazol-3-yl)ethanes.新型1,2-双(1,3,4-恶二唑-2-基)乙烷和1,2-双(4-氨基-1,2,4-三唑-3-基)乙烷系列的合成与抗菌研究
Eur J Med Chem. 2000 Feb;35(2):267-71. doi: 10.1016/s0223-5234(00)00154-9.
9
[Synthesis and antibacterial activity of 3-(5-substituted phenyl-[1,3,4] oxadiazole-2-yl-methylenethio)-5-pyridin-3-yl-[1,2,4] triazole-4-yl-amines].3-(5-取代苯基-[1,3,4]恶二唑-2-基亚甲基硫代)-5-吡啶-3-基-[1,2,4]三唑-4-基胺的合成与抗菌活性
Yao Xue Xue Bao. 2005 Apr;40(4):337-9.
10
Synthesis of some novel 3-(1-(1-substitutedpiperidin-4-yl)-1H-1,2,3-triazol-4-yl)-5-substituted phenyl-1,2,4-oxadiazoles as antifungal agents.合成一些新型的 3-(1-(1-取代哌啶-4-基)-1H-1,2,3-三唑-4-基)-5-取代苯基-1,2,4-恶二唑类化合物作为抗真菌剂。
Eur J Med Chem. 2011 Apr;46(4):1040-4. doi: 10.1016/j.ejmech.2011.01.015. Epub 2011 Jan 20.

引用本文的文献

1
Efficient Synthesis of Various Substituted (Thio)Ureas, Semicarbazides, Thiosemicarbazides, Thiazolidones, and Oxadiazole Derived from [2.2]Paracyclophane.由[2.2]对环芳烷衍生的各种取代(硫代)脲、氨基脲、硫代氨基脲、噻唑烷酮和恶二唑的高效合成
ACS Omega. 2022 Apr 6;7(15):12879-12890. doi: 10.1021/acsomega.2c00141. eCollection 2022 Apr 19.
2
New Paracyclophanylthiazoles with Anti-Leukemia Activity: Design, Synthesis, Molecular Docking, and Mechanistic Studies.具有抗白血病活性的新型骈环芳基噻唑类化合物的设计、合成、分子对接及作用机制研究。
Molecules. 2020 Jul 7;25(13):3089. doi: 10.3390/molecules25133089.

本文引用的文献

1
New Paracyclophanylthiazoles with Anti-Leukemia Activity: Design, Synthesis, Molecular Docking, and Mechanistic Studies.具有抗白血病活性的新型骈环芳基噻唑类化合物的设计、合成、分子对接及作用机制研究。
Molecules. 2020 Jul 7;25(13):3089. doi: 10.3390/molecules25133089.
2
Substituent effect on inter-ring interaction in paracyclophanes.取代基对并环芳烃中环间相互作用的影响。
Mol Divers. 2020 Feb;24(1):11-20. doi: 10.1007/s11030-019-09926-7. Epub 2019 Feb 19.
3
Development of the 1,2,4-triazole-based anticonvulsant drug candidates acting on the voltage-gated sodium channels. Insights from in-vivo, in-vitro, and in-silico studies.
基于 1,2,4-三氮唑的抗惊厥药物候选物的开发作用于电压门控钠离子通道。来自体内、体外和计算研究的见解。
Eur J Pharm Sci. 2019 Mar 1;129:42-57. doi: 10.1016/j.ejps.2018.12.018. Epub 2018 Dec 28.
4
In vitro cytotoxic and in vivo antitumoral activities of some aminomethyl derivatives of 2,4-dihydro-3H-1,2,4-triazole-3-thiones-Evaluation of their acetylcholinesterase and carbonic anhydrase enzymes inhibition profiles.2,4-二氢-3H-1,2,4-三唑-3-硫酮的一些氨甲基衍生物的体外细胞毒性和体内抗肿瘤活性——对其乙酰胆碱酯酶和碳酸酐酶抑制谱的评估
J Biochem Mol Toxicol. 2018 Oct 28:e22239. doi: 10.1002/jbt.22239.
5
Design, synthesis, in silico and in vitro antimicrobial screenings of novel 1,2,4-triazoles carrying 1,2,3-triazole scaffold with lipophilic side chain tether.新型带有亲脂性侧链连接的 1,2,3-三唑骨架的 1,2,4-三唑的设计、合成、计算机模拟和体外抗菌筛选
Chem Cent J. 2017 Nov 21;11(1):117. doi: 10.1186/s13065-017-0347-4.
6
Metal-free enantioselective addition of nucleophilic silicon to aromatic aldehydes catalyzed by a [2.2]paracyclophane-based N-heterocyclic carbene catalyst.一种基于[2.2]对环芳烷的氮杂环卡宾催化剂催化的亲核性硅对芳香醛的无金属对映选择性加成反应。
Org Biomol Chem. 2017 Apr 11;15(15):3202-3206. doi: 10.1039/c7ob00243b.
7
Oxadiazole grafts in peptide macrocycles.恶二唑在肽大环中的接枝。
Nat Chem. 2016 Dec;8(12):1105-1111. doi: 10.1038/nchem.2636. Epub 2016 Oct 24.
8
The structure of the metallo-β-lactamase VIM-2 in complex with a triazolylthioacetamide inhibitor.金属β-内酰胺酶VIM-2与三唑基硫代乙酰胺抑制剂复合物的结构。
Acta Crystallogr F Struct Biol Commun. 2016 Nov 1;72(Pt 11):813-819. doi: 10.1107/S2053230X16016113. Epub 2016 Oct 24.
9
Design, selective alkylation and X-ray crystal structure determination of dihydro-indolyl-1,2,4-triazole-3-thione and its 3-benzylsulfanyl analogue as potent anticancer agents.二氢吲哚基-1,2,4-三唑-3-硫酮及其3-苄基硫烷基类似物作为强效抗癌剂的设计、选择性烷基化及X射线晶体结构测定
Eur J Med Chem. 2017 Jan 5;125:360-371. doi: 10.1016/j.ejmech.2016.09.046. Epub 2016 Sep 15.
10
The preparation of new functionalized [2.2]paracyclophane derivatives with N-containing functional groups.含氮官能团新型官能化[2.2]对环芳烷衍生物的制备
Beilstein J Org Chem. 2015 Apr 7;11:437-45. doi: 10.3762/bjoc.11.50. eCollection 2015.